Mark Michels
Retina Specialist · Palm Beach Gardens, FLNPI 1609880178
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (39.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by US Retina LLC at 39.2% of the total. Reporting peaked in 2022 at $3,557 and has fallen 93.8% since, to $221 in 2025.
Across 79 payments — averaging $96.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$3K
- Genentech, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Genentech USA, Inc.$457
- Novartis$253
- Alimera Sciences, Inc.$146
- plus $1K from 12 others
Across 45 payments — averaging $3616.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$158K
- F. Hoffmann-la Roche AG$5K
What the payments were for
- Consulting fees$1,68022%
- Food & beverage$2,94239%
- Gifts$190%
- Ownership interest$2,99739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $2,997 |
| Genentech, Inc. | 1 | $1,680 |
| Regeneron Healthcare Solutions, Inc. | 34 | $1,015 |
| Genentech USA, Inc. | 14 | $457 |
| Novartis | 5 | $253 |
| Alimera Sciences, Inc. | 3 | $146 |
| Hoffmann-la Roche Limited | 1 | $140 |
| Omeros Corporation | 1 | $125 |
| ANI Pharmaceuticals, Inc. | 1 | $120 |
| Biotissue Holdings Inc. | 1 | $120 |
| AbbVie(2 entities) | 5 | $116 |
| Spark Therapeutics, Inc. | 1 | $106 |
| Aerie Pharmaceuticals, Inc. | 1 | $105 |
| Ocular Therapeutix, Inc. | 1 | $100 |
| Sight Sciences, Inc. | 1 | $90 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,638 in reported general payments places this provider in the 65th percentile of 118 retina specialist providers in Florida.
Other retina specialist in Palm Beach Gardens
- Paul GalloglyPalm Beach Gardens$72K
- Adrian LavinaPalm Beach Gardens$18K
- Philip LairdPalm Beach Gardens$8K
- Julia NemiroffPalm Beach Gardens$3K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.